Boothbay Fund Management’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $470K | Buy |
|
|||||
|
2024
Q3 | $31.8K | Sell |
|
|||||
|
2024
Q2 | $42K | Sell |
|
|||||
|
2024
Q1 | $90.8K | Buy |
|
|||||
|
2023
Q4 | $35.4K | Hold |
|
|||||
|
2023
Q3 | $31.5K | Hold |
|
|||||
|
2023
Q2 | $45.1K | Hold |
|
|||||
|
2023
Q1 | $59K | Hold |
|
|||||
|
2022
Q4 | $50.6K | Hold |
|
|||||
|
2022
Q3 | $56K | Sell |
|
|||||
|
2022
Q2 | $75K | Sell |
|
|||||
|
2022
Q1 | $141K | Hold |
|
|||||
|
2021
Q4 | $186K | Sell |
|
|||||
|
2021
Q3 | $328K | Sell |
|
|||||
|
2021
Q2 | $554K | Sell |
|
|||||
|
2021
Q1 | $916K | Hold |
|
|||||
|
2020
Q4 | $1.41M | Sell |
|
|||||
|
2020
Q3 | $1.09M | Buy |
|
|||||
|
2020
Q2 | $1.29M | Buy |
|
|||||
|
2020
Q1 | $849K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $15K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $246K | Buy |
|
|||||
|
2018
Q3 | $207K | Buy |
|
|||||
|
2018
Q2 | $196K | Buy |
|
|||||
|
2018
Q1 | $75K | Buy |
|